Pneumococcal surface proteins as virulence factors, immunogens, and conserved vaccine targets

J Aceil, FY Avci - Frontiers in cellular and infection microbiology, 2022 - frontiersin.org
Streptococcus pneumoniae is an opportunistic pathogen that causes over 1 million deaths
annually despite the availability of several multivalent pneumococcal conjugate vaccines …

Recent progress in pneumococcal protein vaccines

S Li, H Liang, SH Zhao, XY Yang, Z Guo - Frontiers in Immunology, 2023 - frontiersin.org
Pneumococcal infections continue to pose a significant global health concern, necessitating
the development of effective vaccines. Despite the progress shown by pneumococcal …

PspA-mediated aggregation protects Streptococcus pneumoniae against desiccation on fomites

JR Lane, M Tata, R Yasmin, H Im, DE Briles… - Mbio, 2023 - Am Soc Microbiol
Streptococcus pneumoniae (Spn) resides in the nasopharynx, where it can disseminate to
cause disease. One key Spn virulence factor is pneumococcal surface protein A (PspA) …

The biosynthesis and role of phosphorylcholine in pathogenic and nonpathogenic bacteria

Y Zhang, FEC Jen, KL Fox, JL Edwards… - Trends in …, 2023 - cell.com
Phosphorylcholine (ChoP) can be found in all life forms. Although this molecule was first
thought to be uncommon in bacteria, it is now appreciated that many bacteria express ChoP …

In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface …

E Afshari, RA Cohan… - Journal of Translational …, 2023 - Springer
Background The pathogenicity of pneumococcus with high morbidity, mortality, and multi-
drug resistance patterns has been increasing. The limited coverage of the licensed …

[HTML][HTML] A bacterial vesicle-based pneumococcal vaccine against influenza-mediated secondary Streptococcus pneumoniae pulmonary infection

S Majumder, P Li, S Das, TN Nafiz, S Kumar, G Bai… - Mucosal …, 2024 - Elsevier
Streptococcus pneumoniae (Spn) is a common pathogen causing a secondary bacterial
infection following influenza, which leads to severe morbidity and mortality during seasonal …

Streptococcus pneumoniae epidemiology, pathogenesis and control

AR Narciso, R Dookie, P Nannapaneni… - Nature Reviews …, 2024 - nature.com
Infections caused by Streptococcus pneumoniae (also known as pneumococci) pose a
threat to human health. Pneumococcal infections are the most common cause of milder …

Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections

KF Cardoso, LRA de Souza, BSÁ da Silva Santos… - npj Vaccines, 2024 - nature.com
Streptococcus pneumoniae and influenza A virus (IAV) are significant agents of pneumonia
cases and severe respiratory infections globally. Secondary bacterial infections, particularly …

Pneumococcal surface protein A (PspA) prevents killing of Streptococcus pneumoniae by indolicidin

NT Waz, B Milani, L Assoni, GR Coelho, JM Sciani… - Scientific Reports, 2024 - nature.com
Pneumococcal surface protein A (PspA) is an important virulence factor in Streptococcus
pneumoniae that binds to lactoferrin and protects the bacterium from the bactericidal action …

Negligible role for pneumococcal surface protein A (PspA) and pneumococcal surface protein C (PspC) in the nasopharyngeal colonization of mice with a serotype 6B …

AP Araujo, MLS Oliveira, EN Miyaji - Microbial Pathogenesis, 2023 - Elsevier
Streptococcus pneumoniae colonizes the human nasopharynx asymptomatically, but it can
also cause several diseases, including otitis media, pneumonia, bacteremia, and meningitis …